AU2002363613A1 - Carotenoid composition and method for protecting skin - Google Patents
Carotenoid composition and method for protecting skinInfo
- Publication number
- AU2002363613A1 AU2002363613A1 AU2002363613A AU2002363613A AU2002363613A1 AU 2002363613 A1 AU2002363613 A1 AU 2002363613A1 AU 2002363613 A AU2002363613 A AU 2002363613A AU 2002363613 A AU2002363613 A AU 2002363613A AU 2002363613 A1 AU2002363613 A1 AU 2002363613A1
- Authority
- AU
- Australia
- Prior art keywords
- composition
- carotenoid
- lycopene
- phytofluene
- phytoene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Description
Carotenoid Composition and Method for Protecting Skin
Field of the Invention
The present invention relates to the field of protection from sun radiation, particularly to methods and compositions effective in protecting skin.
Background of the Invention
It is well established that prolonged exposure to sun has damaging effects on the skin. Particularly, the uv radiation from the sun is known to cause erythema of the skin, sunburn and skin cancer. Protection of the skin from uv radiation can be achieved by protective attire as well as by protection in the form of topical compositions of various protective ingredients. A particular group of protective compositions are intended for oral administration. Oral compositions contain active ingredients which are delivered to the skin via an internal transport mechanism and thus protect the skin from uv radiation damage. A particular group of active ingredients which are suitable for use with said oral compositions are carotenoids. U.S. patent 3,920,834 describes the use of a mixture of carotenoids wherein cathaxanthin is the primary carotenoid in the composition. However, the use of cathaxanthin is known to be limited due to adverse effects it may have on pigmentation. U.S. patent 5,290,605 describes food-stuff and beverages intended for providing protection to the skin against uv sun radiation. Said foodstuff and beverages comprising carotenoids as well as ascorbic acid, tocopherols, coenzyme Q10 and reduced glutathione. U.S. patent 6,110,478 further describes a composition for protecting skin against uv radiation and the harmful effects thereof, wherein the composition contains a pro-vitamin A carotenoid and lycopene. The use of such a composition is limited by the negative effect pro-vitamin A carotenoids may have on the subject's health at certain dosage levels. An excess of vitamin A, which is produced in the body from pro-vitamin A carotenoids, was found to have adverse effects on health. Stahl et al ("Dietary Tomato Paste Protects against Ultraviolet Light-induced Erythema in Humans", Biochemical and Molecular Action of Nutrients, Research Communication, (2001) 1449-1451) have shown the protective effect of tomato paste which is known to contain inter alia lycopene, β- carotene and tocopherol, against uv light-induced erythema. However, Stahl has reported
a problem in achieving desired carotenoid serum levels, suggesting poor bioavailability.
Accordingly, there is a long felt need to develop a composition for protecting skin against uv radiation which is suitable for oral administration and is safe at a wide range of dosages.
It is therefore a purpose of the present invention to provide a method for protecting skin against damages caused by ultra-violet (uv) radiation from the sun.
A further purpose of the present invention is to provide a carotenoid composition effective in protecting the skin against the damages of uv radiation and which does present potential health risks.
It is yet another purpose of the present invention to provide a method and composition that overcome the disadvantages of the known art.
Other objectives of the invention will become apparent as the description proceeds.
Summary of the Invention The present invention provides a method for protecting skin against damages caused by ultra-violet (uv) radiation from the sun, comprising administering to a subject in need of protection an effective amount of a composition containing lycopene from a natural source and one or more carotenoid selected from among a group consisting of phytoene and phytofluene. Optionally, said composition may further contain vitamin E.
Further provided by the present invention is a composition comprising of 6% to 25% lycopene of a natural source and more than 0.3% of one or more carotenoid selected from among a group consisting of phytoene and phytofluene. Optionally, said composition may contain 1% to 4% vitamin E.
Further provided by the present invention is the use of a carotenoid composition containing lycopene from a natural source and one or more carotenoid selected from among a group consisting of phytoene and phytofluene as a protective agent against uv light-induced damage to skin. Optionally, said composition may further contain vitamin E.
The present invention further provides administration forms for the presently claimed composition, wherein said administration form may be a food-stuff, beverage or pharmaceutically acceptable dosage form.
Description of the Drawings
Fig. I - Comparison of protection of various carotenoid compositions against erythema
(see Example 2 for clarifications of terms appearing in graph)
Detailed Description of a Preferred Embodiment of the Invention
The following description is illustrative of embodiments of the invention. The following description is not to be construed as limiting, it being understood that the skilled person may carry out many obvious variations to the invention.
Throughout the description, percentages of components are by weight, unless specifically noted differently. The terms "lycopene of natural sources" and "natural lycopene" are synonymous throughout the application and refer to lycopene from vegetables, fruits, plant matter, fungus and fungal sources, and natural bio-mass.
It has surprisingly been found that carotenoid compositions which contain natural lycopene and one or more carotenoid selected from among a group consisting of phytoene and phytofluene, are effective in protecting skin against damages caused by uv radiation from the sun, wherein said damages are erythema and sunburn. Furthermore, unexpectedly, it has been found in the present invention that natural lycopene is significantly more effective in protecting skin against uv radiation damages than synthetic lycopene. A further surprising finding according to the present invention, is that the
addition of phytoene and/or phytofluene to the natural lycopene composition improves the effectiveness of the composition in protecting skin against uv radiation damage.
According to an embodiment of the method of the present invention, 1 mg to 10 mg of a composition comprising 6% to 15% of natural lycopene and 0.3% to 1.5% of one or more carotenoid selected from among phytoene and phytofluene are administered to a subject. Preferably, about 5 mg of a composition comprising 6% of natural lycopene, 0.5% phytoene and 0.5% phytofluene are administered.
In yet a further embodiment of the present method the aforementioned compositions may contain 1.5% to 2.5% of vitamin E. preferably, said composition containing about 6% natural lycopene, 0.5% phytoene, 0.5% phytofluene and 2% vitamin E.
According to a particular embodiment of the invention, the compositions employed comprise natural lycopene and one or more additional carotenoid selected from among phytoene and phytofluene wherein the ratio between the lycopene and additional carotenoids is in the range of 20:1 to 5:1, preferably 8:1 to 5:1.
The indicated dosages refer to a healthy adult in the weight range of 50 Kg to 70 Kg and thus may vary according to body size. However, preferably, the dosage is adjusted so that the carotenoid serum level of the subject reaches a level within the range of 0.3 to 1.2 μM (micromole/liter), wherein serum levels of lycopene are 0.2 to 0.6 μM, phytoene 0.08 to 0.2 μM and phytofluene 0.08 to 0.4 μM. Dosages of total carotenoids may be daily in single or multiple doses, of about 2 to 15 mg/day, preferably 5 mg/day.
The compositions are administered by means known in the art, which will achieve the desired carotenoid serum levels. Oral administration is preferred. The oral administration can be in the form of a capsule, gel-cap, pellet, soft gel capsule or tablet which contain the carotenoid compositions. Said oral dosage forms may contain pharmaceutically acceptable excipients, additives, carriers and stabilizers. Particularly important additives are of the type which improve bioavailability of the carotenoids, e.g. oils and surfactants.
Said oral dosage forms are prepared according to conventional methods known from the art. A preferred means of oral administration is via foodstuff and beverages. Thus, the carotenoid composition is added to foodstuff or beverages. The amount of carotenoid composition in the foodstuff and beverage is adjusted to meet the above-mentioned dosages.
According to a particular embodiment of the present method, administration of the composition is preferably started before exposure to uv radiation. Preferably, 7 to 30 days before exposure, and administration is continued during exposure.
According to a further aspect of the present invention there is provided a novel carotenoid composition comprising of 6% to 15% lycopene of a natural source and 0.3% to 1.5% of one or more carotenoid selected from among a group consisting of phytoene and phytofluene. Preferably, the composition comprises 6% of natural lycopene, 0.5% phytoene and 0.5% phytofluene.
According to yet a further embodiment the composition may further comprise of 1.5% to 2.5% vitamin E. Preferably the composition contains 6% natural lycopene, 0.5% phytoene, 0.5% phytofluene and 2% vitamin E.
The compositions of the present invention comprise natural lycopene and one or more additional carotenoid selected from among a group consisting of phytoene and phytofluene wherein the ratio between the lycopene and additional carotenoid is in the range of 20:1 to 5:1, preferably 8:1 to 5:1. Optionally, the composition may further contain vitamin E wherein the ratio between the lycopene and the vitamin E is in the range of 10:1 to 2:1, preferably 8:1 to 3:1.
A particular embodiment of the present invention relates to solid and liquid oral dosage forms selected from among a group comprising of a capsule, gel-cap, pellet, soft gel capsule, tablet, or other liquid or solid oral dosage forms known in the art, which comprises a carotenoid composition which contains 5 mg to 15 mg of natural lycopene
and 0.5 mg to 3.5 mg of one or more additional carotenoid selected from among phytoene and/or phytofluene. Said oral dosage form may further comprise 1.5 mg to 8 mg of vitamin E. Preferably, said oral dosage form comprises 5 mg of natural lycopene, 0.5 mg phytoene, 0.45 mg phytofluene and 1.8 mg of vitamin E. Said dosage form may further contain a pharmaceutically acceptable adjuvant, excepient, carrier, filler, stabilizer or additive.
The present invention further relates to foodstuff or beverages which contains a carotenoid composition as described herein. The foodstuff or beverage contain 5 mg to 15 mg of natural lycopene and 0.5 mg to 3.5 mg of one or more carotenoid selected from among a group consisting of phytoene and phytofluene. Said food-stuff or beverage may further contain 1.5 mg to 8 mg of vitamin E. Preferably, said food-stuff or beverage comprises 4.1 mg of natural lycopene, 2.2 mg phytoene, 1.6 mg phytofluene and 3.8 mg of vitamin E.
The present invention presents the following advantages:
1. The compositions do not contain pro-vitamin A carotenoids, which at certain elevated dosages may be a health hazard. Thus, the present invention is safer and does not have the health risks as compositions described in the prior art.
2. The protection is provided via in- vivo activity. Thus, the protective composition cannot be washed away or depleted like topical protective compositions.
3. The compositions of the present invention have been shown to have improved bioavailability compared to other sources of natural lycopene and in comparison to synthetic lycopene, and thus offer improved protection against uv light-induced skin damage.
4. The composition may bring about tanning of the skin to a brown hue in subjects exposed to uv radiation without the damages associated with uv radiation. This has both health and aesthetic advantages.
Examples
Example 1: Preparation of Carotenoid Composition
The lycopene used throughout the Examples is natural lycopene by LycoRed®.
Formulation 1 : each capsule contains:
Lycopene 4.88 mg Phytoene 0.48 mg
Phytofluene 0.44 mg
Vitamin E 1.81 mg in soft gel capsules which are prepared according to standard procedures known to the skilled artisan.
Formulation II: each soft drink bottle contains
Lycopene 4.1 mg
Phytoene 2.2 mg
Phytofluene 1.6 mg Vitamin E 3.8 mg
Formulation III Lycopene 5.5 mg Vitamin E 2.0 mg
Example 2: Comparative Example of Protection against erythema
Three treatment groups consumed the following lycopene supplements for 12 weeks: a) Group 1 - Lyc-O-Mato® soft gel capsules^ (1 capsule twice a day) b) Group 2 - Lyc-O-Guard™ drink2) (250 ml bottle twice a day) c) Group 3 - Synthetic lycopene hard shell capsules3) (1 capsule twice a day)
1) The carotenoid fraction is a tomato extract containing natural lycopene, phytoene, phytofluene and tocopherols. 2) The carotenoid fraction is a tomato extract similar to Lyc-O-Mato® which is further enriched with phytoene, phytofluene and tocopherols. 3) The carotenoid fraction contains synthetic lycopene and tocopherols.
The minimal erythema dose (MED), which is the minimal dose of uv radiation which produces a minimal erythema (reddening of the skin) after 24 hours was determined by exposing different small areas of skin to increasing doses of uv radiation. The testing of the effectiveness of the carotenoid supplementation was tested by exposing the subjects to 1.25 of the individual MED at 0, 4 and 12 weeks from the beginning of lycopene supplementation. The effect of the radiation on the reddening and pigmentation of the skin was measured by a Minolta chronometer. The "a" and "b" value of the chronometer correlate to the reddening and pigmentation of the skin, respectively. The erythema (reddening) was determined 24 hours after radiation of uv radiation, by subtracting the value of "a" before radiation from the value of "a" 24 hours after radiation. The value obtained is denoted by "Δa". Larger values of Δa correlate with increased erythema of the skin. Fig. 1 clearly demonstrates the improved protective effect against uv induced erythema, Lyc-O-Mato and Lyc-O- Guard have over synthetic lycopene.
While embodiments of the invention have been described by way of illustration, it will be apparent that the invention may be carried out with many modifications, variations and adaptations, without departing from its spirit or exceeding the scope of the claims.
Claims
1. A method for protecting skin against damages caused by ultra-violet (uv) radiation from the sun, comprising administering to a subject in need of protection an effective amount of a composition containing lycopene from a natural source and one or more carotenoid selected from among phytoene and phytofluene or mixtures thereof.
2. A method according to claim 1 wherein said composition further contains vitamin E.
3. A method according to claim 1, wherein 1 mg to 10 mg of a carotenoid composition comprising of 6% to 15% lycopene of a natural source and 0.3% to 1.5% of one or more carotenoid selected from among phytoene and phytofluene or mixtures thereof are administered.
4. A method according to claim 3 wherein said composition contains 1.5% to 2.5% vitamin E.
5. A method according to claim 3, wherein about 5 mg are administered.
6. A method according to claim 4, wherein about 5 mg are administered.
7. A method according to any of claims 1 to 6 wherein the carotenoid serum level of the subject reaches a level within the range of 0.3 to 1.5 μM.
8. A method according to claim 8 wherein carotenoid serum levels of the subject reaches a level of about 1.2 μM.
9. A method according to any one of claims 1 to 8 wherein administration is in the form of a capsule, gel-cap, pellet, soft gel capsule or tablet which contain the carotenoid compositions.
10. A method according to any one of claims 1 to 8 wherein administration is in the form of oral administration via foodstuff or beverages.
11. A method according to any one of claims 1 to 11 wherein administration begins 7 to 30 days before exposure to uv radiation.
12. A carotenoid composition comprising of 6% to 15% lycopene of a natural source and 0.3% to 1.5% of one or more carotenoid selected from among phytoene and phytofluene or mixtures thereof.
13. A composition according to claim 12 further containing 1.5% to 2.5% vitamin E.
14. A composition according to claim 12 which contains about 6% natural lycopene, 0.5% phytoene and 0.5% phytofluene.
15. A composition according to claim 13 which contains about 6% natural lycopene, 0.5% phytoene, 0.5% phytofluene and 2% vitamin E.
16. An oral dosage form comprising of 5 mg to 15 mg of natural lycopene and 0.5 mg to 3.5 mg of one or more carotenoid selected from among phytoene and/or phytofluene or mixtures thereof.
17. An oral dosage form according to claim 16 further comprising 1.5 mg to 8 mg of vitamin E.
18. An oral dosage form according to claim 17 comprising 5 mg of natural lycopene, 0.5 mg phytoene, 0.45 mg phytofluene and 1.8 mg of vitamin E.
19. An oral dosage form according to claim 16 further containing a pharmaceutically acceptable adjuvant, excepient, carrier, filler, stabilizer or additive.
20. Use of a composition as described in any of claims 12 to 15 in the preparation of a skin protecting composition.
21. Use of a composition as described in any of claims 12 to 15 as a skin-protecting agent.
22. A composition according to any of claims 12 to 15 for use in the protection of skin against damages caused by uv radiation.
23. Foodstuff and beverage containing a composition as described in any of claims 12 to 15.
24. Foodstuff or beverage comprising of 5 mg to 15 mg of natural lycopene and 0.5 mg to 3.5 mg of one or more carotenoid selected from among a group consisting of phytoene and phytofluene.
25. Foodstuff or beverage according to claim 24 further comprising 1.5 mg to 8 mg of vitamin E.
26. Foodstuff or beverage according to claim 25 comprising 4.1 mg of natural lycopene, 2.2 mg phytoene, 1.6 mg phytofluene and 3.8 mg of vitamin E.
27. A pharmaceutically acceptable oral dosage form containing a composition as described in any of claims 12 to 15.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL14649601A IL146496A0 (en) | 2001-11-14 | 2001-11-14 | Carotenoid composition and method for protecting skin |
| IL146496 | 2001-11-14 | ||
| PCT/IL2002/000875 WO2003041678A1 (en) | 2001-11-14 | 2002-11-05 | Carotenoid composition and method for protecting skin |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2002363613A1 true AU2002363613A1 (en) | 2003-07-24 |
| AU2002363613B2 AU2002363613B2 (en) | 2007-08-02 |
Family
ID=11075862
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002363613A Expired AU2002363613B2 (en) | 2001-11-14 | 2002-11-05 | Carotenoid composition and method for protecting skin |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US20050053559A1 (en) |
| EP (1) | EP1443897B1 (en) |
| JP (2) | JP2005515179A (en) |
| KR (1) | KR20050043788A (en) |
| CN (1) | CN100391433C (en) |
| AU (1) | AU2002363613B2 (en) |
| BR (1) | BR0214197A (en) |
| CA (1) | CA2467056C (en) |
| ES (1) | ES2641737T3 (en) |
| IL (3) | IL146496A0 (en) |
| NO (1) | NO20041803L (en) |
| PL (1) | PL209422B1 (en) |
| RU (1) | RU2341252C2 (en) |
| WO (1) | WO2003041678A1 (en) |
| ZA (1) | ZA200403529B (en) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL141039A (en) * | 2001-01-23 | 2006-10-31 | Lycored Natural Prod Ind Ltd | Anti-atherosclerosis composition containing carotenoids and use in the preparation of medicaments for inhibiting ldl oxidation |
| ATE424898T1 (en) * | 2003-08-21 | 2009-03-15 | Nestec Sa | NATURAL LYCOPEN CONCENTRATES AND PROCESS FOR PRODUCTION |
| DE10349983A1 (en) | 2003-10-24 | 2005-05-25 | Basf Ag | Process for the preparation of phytofluene |
| US9579298B2 (en) | 2004-12-02 | 2017-02-28 | Piotr Chomczynski | Antioxidant dietary supplement compositions and methods for maintaining healthy skin |
| IL176668A0 (en) | 2006-07-02 | 2006-10-31 | Ibr Ltd | Colorless carotenoids for skin whitening |
| US20080287508A1 (en) * | 2007-05-18 | 2008-11-20 | Intermune, Inc. | Altering pharmacokinetics of pirfenidone therapy |
| FR2985064B1 (en) * | 2011-12-23 | 2016-02-26 | Oreal | METHOD FOR DELIVERING COSMETIC ADVICE |
| JP6012415B2 (en) * | 2012-11-09 | 2016-10-25 | アサヒグループホールディングス株式会社 | Drunkenness reducing agent |
| CN103536506A (en) * | 2013-10-15 | 2014-01-29 | 倪生标 | Sunscreen lotion |
| CN104188812A (en) * | 2014-09-02 | 2014-12-10 | 青岛永通电梯工程有限公司 | Physical sunscreen cream |
| CN104323936A (en) * | 2014-09-30 | 2015-02-04 | 青岛康和食品有限公司 | Sunblocking cream |
| CN108379563A (en) * | 2018-05-14 | 2018-08-10 | 青岛琛蓝海洋生物工程有限公司 | A kind of radiation protection composition and preparation method thereof |
| KR102846921B1 (en) | 2018-07-23 | 2025-08-21 | 라이코드 리미티드 | Lycopene composition and method for protecting skin from ultraviolet rays |
| CA3153568A1 (en) * | 2019-10-10 | 2021-04-15 | Tal Offer | Compositions comprising caroternoids and methods for inhibiting collagen loss |
| US20230181490A1 (en) * | 2020-05-07 | 2023-06-15 | Lycored Ltd. | Pro-lycopene rich composition and methods of using same |
| GB202109087D0 (en) | 2021-06-24 | 2021-08-11 | Norwegian Univ Sci & Tech Ntnu | Therapeutic methods and devices |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3920834A (en) * | 1970-07-10 | 1975-11-18 | Hoffmann La Roche | Light-screening compositions and method |
| US5290605A (en) * | 1989-06-29 | 1994-03-01 | Niva Shapira | Sun-exposure nutritional supporting composition |
| US6132790A (en) * | 1991-09-06 | 2000-10-17 | Betatene Limited | Carotenoid composition |
| RU2058133C1 (en) * | 1992-06-24 | 1996-04-20 | Парфюмерно-косметическая фабрика "Виорика" | Face cream |
| FR2698268B1 (en) * | 1992-11-24 | 1995-01-20 | Oreal | Photoprotective composition administered orally. |
| US5643623A (en) * | 1995-06-07 | 1997-07-01 | Mars Incorporated | Health food product and its uses |
| FR2749758B1 (en) * | 1996-06-12 | 1998-08-07 | Oenobiol Sa Lab | COMPOSITION WITH TANNING AND PHOTOPROCTOR ACTIVITY AND ITS AESTHETIC APPLICATIONS |
| IL118697A (en) * | 1996-06-20 | 1999-12-31 | Lycored Natural Prod Ind Ltd | Industrial processing of tomatoes |
| US6110748A (en) * | 1997-04-30 | 2000-08-29 | Motorola, Inc. | Optical storage medium for binding assays |
| EP0938846B1 (en) | 1998-02-13 | 2004-04-14 | Societe Des Produits Nestle S.A. | Garnished toast |
| IL126076A (en) * | 1998-09-04 | 2005-05-17 | Ibr Ltd | Transparent composition comprising phytoene and phytofluene |
| FR2805742B3 (en) * | 2000-03-03 | 2002-05-10 | I B R Isareli Biotechnology Re | COLORLESS PREPARATION COMPRISING CAROTENOIDS |
| JP2003532680A (en) * | 2000-05-12 | 2003-11-05 | クリスター オルソン,ベント | Composite composition of marine extract and plant extract |
| IL141038A (en) * | 2001-01-23 | 2006-10-05 | Lycored Natural Prod Ind Ltd | Use of carotenoids in the preparation of anti-hypertension agents |
| AU2003205737A1 (en) | 2002-02-15 | 2003-09-04 | Humboldt Universitaet | Compositions comprising lycopene for the treatment and prevention of angiogenesis associated pathologies |
| EP1569628B1 (en) | 2002-12-06 | 2009-07-22 | DSM IP Assets B.V. | Novel use of lycopene for the treatment of diseases associated with androgen signalling |
| EP1938810B1 (en) | 2005-09-30 | 2014-06-18 | Fuji Chemical Industry Co., Ltd. | Ameliorating agent for metabolic syndrome |
| EP2020997A2 (en) | 2006-05-15 | 2009-02-11 | DSMIP Assets B.V. | Novel actives against prostate carcinoma |
| IL184575A0 (en) | 2007-07-12 | 2008-01-20 | Lycored Ltd | Synergistic combinations for treating hypertension |
| EP3085365A3 (en) | 2009-01-19 | 2017-01-04 | Lycored Ltd. | Synergistic combinations of carotenoids and polyphenols |
| JP2010208972A (en) | 2009-03-09 | 2010-09-24 | Kao Corp | Endothelin expression inhibitor |
| AU2010314956A1 (en) | 2009-11-06 | 2012-04-12 | Alcon Research, Ltd. | Nutritional supplements for relief of dry eye |
| ES2882192T3 (en) | 2013-03-19 | 2021-12-01 | Lycored Ltd | Synergistic anti-inflammatory combinations of astaxanthin with lycopene and carnosic acid |
-
2001
- 2001-11-14 IL IL14649601A patent/IL146496A0/en unknown
-
2002
- 2002-11-05 WO PCT/IL2002/000875 patent/WO2003041678A1/en not_active Ceased
- 2002-11-05 IL IL16170402A patent/IL161704A0/en unknown
- 2002-11-05 RU RU2004114283/14A patent/RU2341252C2/en active
- 2002-11-05 AU AU2002363613A patent/AU2002363613B2/en not_active Expired
- 2002-11-05 US US10/495,514 patent/US20050053559A1/en not_active Abandoned
- 2002-11-05 ES ES02803083.1T patent/ES2641737T3/en not_active Expired - Lifetime
- 2002-11-05 PL PL368855A patent/PL209422B1/en unknown
- 2002-11-05 CA CA2467056A patent/CA2467056C/en not_active Expired - Lifetime
- 2002-11-05 KR KR1020047007216A patent/KR20050043788A/en not_active Ceased
- 2002-11-05 EP EP02803083.1A patent/EP1443897B1/en not_active Expired - Lifetime
- 2002-11-05 BR BR0214197-3A patent/BR0214197A/en not_active Application Discontinuation
- 2002-11-05 JP JP2003543565A patent/JP2005515179A/en not_active Withdrawn
- 2002-11-05 CN CNB028224841A patent/CN100391433C/en not_active Expired - Lifetime
-
2004
- 2004-04-29 IL IL161704A patent/IL161704A/en active IP Right Grant
- 2004-05-03 NO NO20041803A patent/NO20041803L/en not_active Application Discontinuation
- 2004-05-10 ZA ZA200403529A patent/ZA200403529B/en unknown
-
2009
- 2009-03-18 US US12/406,762 patent/US10420715B2/en not_active Expired - Fee Related
-
2012
- 2012-05-01 JP JP2012104722A patent/JP6125760B2/en not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10420715B2 (en) | Carotenoid composition and method for protecting skin | |
| AU2002363613A1 (en) | Carotenoid composition and method for protecting skin | |
| US7588785B2 (en) | Methods and kits for reducing cellular damage, inhibiting free radical production and scavenging free radicals | |
| KR100539633B1 (en) | Nutritional Supplement to Treat Macular Degeneration | |
| US20050249821A1 (en) | Nutritional supplement for treatment of ocular diseases | |
| US20080171032A1 (en) | Dietary supplement composition and method of use for the treatment and prevention of oxidative stress | |
| US20040259959A1 (en) | Method and pharmaceutical preparation for reducing the activity of cells | |
| US5948823A (en) | Irradiation protection method | |
| KR20080045083A (en) | How to suppress light-induced skin carcinogenesis | |
| US20080014156A1 (en) | Photoprotectant composition for preventing sunburn and sun damage to the skin | |
| AU7281300A (en) | Sunscreen agent for oral administration | |
| EP0712630A2 (en) | Oral composition for the prevention of sun allergies containing a carotenoid, a tocopherol, ascorbic acid and selenium | |
| Singh et al. | Antioxidants the powerful new weapons in the fight against periodontal diseases | |
| Afshar et al. | Endogenous Antioxidant Photoprotection and Its Enhancement in Human Skin | |
| Smith | Immunomodulation and Antioxidant Nutraceuticals | |
| EP2952104A1 (en) | Composition and method for preventing damage of human cells by ionising radiation | |
| Kornhauser et al. | β-Carotene Protection Against Phototoxicity In Vivo | |
| AU2002348711A1 (en) | Method and pharmaceutical preparations for reducing the activity of cells | |
| IES68517B2 (en) | Anti-oxidant formulations |